The Tools and Levers of Access to Patented Health Related Genetic Invention in Canada

Abstract

This Article argues that there is a prevailing problem of access to genetic invention in Canada caused by disputes over intellectual property rights arising from conflicting normative orders.

Keywords

Patents -- Canada, Genetics, Health care industry -- Canada, Health care industry -- Law & legislation, Gene therapy, Generic drugs, Health care services accessibility, Patent licensing, Bayh-Dole Act, Canada, United States

Share

Authors

S. Tina Piper (McGill University)

Download

Issue

Publication details

Dates

Licence

All rights reserved

File Checksums (MD5)

  • pdf: 84477d1730407b13eda0e64bd4425e93